Peter Tyrer

786 total citations
23 papers, 566 citations indexed

About

Peter Tyrer is a scholar working on Oncology, Molecular Biology and Neurology. According to data from OpenAlex, Peter Tyrer has authored 23 papers receiving a total of 566 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 6 papers in Molecular Biology and 5 papers in Neurology. Recurrent topics in Peter Tyrer's work include CAR-T cell therapy research (5 papers), Escherichia coli research studies (5 papers) and Synthesis and pharmacology of benzodiazepine derivatives (4 papers). Peter Tyrer is often cited by papers focused on CAR-T cell therapy research (5 papers), Escherichia coli research studies (5 papers) and Synthesis and pharmacology of benzodiazepine derivatives (4 papers). Peter Tyrer collaborates with scholars based in United Kingdom, Australia and New Zealand. Peter Tyrer's co-authors include A. Ruth Foxwell, Allan W. Cripps, Jennelle M. Kyd, Jacqueline I. Keenan, Francesca Zammarchi, Patrick H. van Berkel, John A. Hartley, Michael A. Apicella, Philip W. Howard and David G. Williams and has published in prestigious journals such as Blood, Gastroenterology and Cancer Research.

In The Last Decade

Peter Tyrer

23 papers receiving 543 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Tyrer United Kingdom 13 239 144 124 122 79 23 566
Bei Wang United States 16 154 0.6× 207 1.4× 118 1.0× 270 2.2× 41 0.5× 23 640
Ana Maria Moro Brazil 15 111 0.5× 244 1.7× 209 1.7× 127 1.0× 15 0.2× 48 602
Masanori Matsumoto Japan 11 75 0.3× 139 1.0× 101 0.8× 198 1.6× 20 0.3× 29 653
Anaamika Campeau United States 12 171 0.7× 290 2.0× 95 0.8× 79 0.6× 11 0.1× 23 618
Michela Spadaro Italy 18 322 1.3× 334 2.3× 195 1.6× 599 4.9× 41 0.5× 39 1.1k
Page Bouchard United States 14 283 1.2× 438 3.0× 100 0.8× 511 4.2× 21 0.3× 22 1.1k
Petra Schulz Germany 20 178 0.7× 391 2.7× 123 1.0× 192 1.6× 25 0.3× 66 1.3k
Linda Stein United States 13 61 0.3× 156 1.1× 148 1.2× 82 0.7× 25 0.3× 18 754
Mohit Gupta United States 15 104 0.4× 1.0k 7.2× 72 0.6× 196 1.6× 27 0.3× 22 1.4k
Peter Laing United Kingdom 10 42 0.2× 241 1.7× 117 0.9× 145 1.2× 10 0.1× 22 732

Countries citing papers authored by Peter Tyrer

Since Specialization
Citations

This map shows the geographic impact of Peter Tyrer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Tyrer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Tyrer more than expected).

Fields of papers citing papers by Peter Tyrer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Tyrer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Tyrer. The network helps show where Peter Tyrer may publish in the future.

Co-authorship network of co-authors of Peter Tyrer

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Tyrer. A scholar is included among the top collaborators of Peter Tyrer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Tyrer. Peter Tyrer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zammarchi, Francesca, Karin Havenith, Narinder Janghra, et al.. (2024). ADCT-602, a Novel PBD Dimer–containing Antibody–Drug Conjugate for Treating CD22-positive Hematologic Malignancies. Molecular Cancer Therapeutics. 23(4). 520–531. 6 indexed citations
2.
Zammarchi, Francesca, Karin Havenith, Simon Chivers, et al.. (2018). Abstract 2792A: Preclinical activity of ADCT-601, a novel pyrrolobenzodiazepine (PBD) dimer-based antibody-drug conjugate (ADC) targeting AXL-expressing tumors. Cancer Research. 78(13_Supplement). 2792A–2792A. 4 indexed citations
3.
Zammarchi, Francesca, Simon Corbett, Lauren Adams, et al.. (2018). ADCT-402, a PBD dimer–containing antibody drug conjugate targeting CD19-expressing malignancies. Blood. 131(10). 1094–1105. 118 indexed citations
4.
Zammarchi, Francesca, Karin Havenith, Simon Chivers, et al.. (2018). Abstract 744: ADCT-701, a novel pyrrolobenzodiazepine (PBD) dimer-based antibody-drug conjugate (ADC) targeting DLK1-expressing tumors. Cancer Research. 78(13_Supplement). 744–744. 4 indexed citations
5.
Zammarchi, Francesca, Narinder Janghra, Simon Corbett, et al.. (2017). Abstract 52: Mechanistic and benchmarking studies of ADCT-502, a pyrrolobenzodiazepine (PBD) dimer-containing antibody-drug conjugate (ADC) targeting HER2-expressing solid tumors. Cancer Research. 77(13_Supplement). 52–52. 4 indexed citations
6.
Zammarchi, Francesca, Simon Chivers, Karin Havenith, et al.. (2017). Abstract 3111A: ADCT-401/MEDI3726, a novel pyrrolobenzodiazepine (PBD)-based antibody-drug conjugate (ADC) targeting PSMA-expressing prostate cancers. Cancer Research. 77(13_Supplement). 3111A–3111A. 1 indexed citations
7.
Flynn, Michael, Francesca Zammarchi, Peter Tyrer, et al.. (2016). ADCT-301, a Pyrrolobenzodiazepine (PBD) Dimer–Containing Antibody–Drug Conjugate (ADC) Targeting CD25-Expressing Hematological Malignancies. Molecular Cancer Therapeutics. 15(11). 2709–2721. 85 indexed citations
8.
Zammarchi, Francesca, Simon Chivers, David G. Williams, et al.. (2016). ADCT-502, a novel pyrrolobenzodiazepine (PBD)-based antibody–drug conjugate (ADC) targeting low HER2-expressing solid cancers. European Journal of Cancer. 69. S28–S28. 14 indexed citations
9.
Flynn, Michael, Patrick H. van Berkel, Francesca Zammarchi, et al.. (2015). Mechanistic and Pharmacodynamic Studies of Adct-301, a Pyrrolobenzodiazepine (PBD) Dimer-Containing Antibody Drug Conjugate (ADC) Targeting CD25-Expressing Hematological Malignancies. Blood. 126(23). 1559–1559. 6 indexed citations
10.
Tyrer, Peter, Frank Frizelle, & Jacqueline I. Keenan. (2014). Escherichia coli-derived outer membrane vesicles are genotoxic to human enterocyte-like cells. Infectious Agents and Cancer. 9(1). 2–2. 38 indexed citations
11.
Heinemann, Jack A., et al.. (2012). Human lactoferrin increases Helicobacter pylori internalisation into AGS cells. World Journal of Microbiology and Biotechnology. 28(5). 1871–1880. 6 indexed citations
12.
Tyrer, Peter, et al.. (2011). Effects of bacterial products on enterocyte–macrophage interactions in vitro. Biochemical and Biophysical Research Communications. 413(2). 336–341. 15 indexed citations
13.
Nelson, Michelle, A. Ruth Foxwell, Peter Tyrer, & Roger T. Dean. (2010). Radical sequestration by protein-bound 3,4-dihydroxyphenylalanine. The International Journal of Biochemistry & Cell Biology. 42(5). 755–761. 4 indexed citations
14.
Tyrer, Peter, et al.. (2007). Receptor mediated targeting of M-cells. Vaccine. 25(16). 3204–3209. 35 indexed citations
15.
Nelson, Michelle, A. Ruth Foxwell, Peter Tyrer, & Roger T. Dean. (2006). Protein-bound 3,4-dihydroxy-phenylanine (DOPA), a redox-active product of protein oxidation, as a trigger for antioxidant defences. The International Journal of Biochemistry & Cell Biology. 39(5). 879–889. 13 indexed citations
16.
Tyrer, Peter, A. Ruth Foxwell, Allan W. Cripps, Michael A. Apicella, & Jennelle M. Kyd. (2005). Microbial Pattern Recognition Receptors Mediate M-Cell Uptake of a Gram-Negative Bacterium. Infection and Immunity. 74(1). 625–631. 77 indexed citations
17.
Tyrer, Peter, et al.. (2002). Validation and quantitation of an in vitro M-cell model. Biochemical and Biophysical Research Communications. 299(3). 377–383. 48 indexed citations
18.
Tyrer, Peter, et al.. (2002). The measurement of engagement in the homeless mentally ill: the Homeless Engagement and Acceptance Scale – HEAS. Psychological Medicine. 32(5). 855–861. 33 indexed citations
19.
Tyrer, Peter, Siobhán Murphy, & R T Owen. (1985). The risk of pharmacological dependence with buspirone.. PubMed. 38. 91–4. 22 indexed citations
20.
Tyrer, Peter. (1973). Selection of Patients for Clinical Trials. BMJ. 4(5888). 358–358. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bei Wang Breakdown of academic impact, for papers by Ana Maria Moro Breakdown of academic impact, for papers by Masanori Matsumoto Breakdown of academic impact, for papers by Anaamika Campeau Breakdown of academic impact, for papers by Michela Spadaro Breakdown of academic impact, for papers by Page Bouchard Breakdown of academic impact, for papers by Petra Schulz Breakdown of academic impact, for papers by Linda Stein Breakdown of academic impact, for papers by Mohit Gupta Breakdown of academic impact, for papers by Peter Laing
Rankless by CCL
2026